6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
Just now	Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
Just now	Duos Technologies to Participate at the 23rd Annual Craig-Hallum Institutional Investor Conference
Just now	ReconAfrica Announces First Quarter Filings
1m ago	Matrix Service Company to Participate at Upcoming Stifel Cross-Sector Insight Conference June 2-3, 2026

About

257.42USD+3.73 +1.47%

Closed • Updated at 13:09 GMT+00:00

Market Cap$21.11B

P/E Ratio22.81

Volume400.2K

Beta0.33

RSI47.58

Gross Margin26.81%

Health ServicesMedical/Nursing Services

Labcorp Holdings Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time

Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems

Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance

SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio

Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®

Community Chat

Ask AI